BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21656514)

  • 21. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a scientific presentation on community treatment patterns for primary breast cancer.
    Giordano SH; Duan Z; Kuo YF; Hortobagyi GN; Freeman J; Goodwin JS
    J Natl Cancer Inst; 2006 Mar; 98(6):382-8. PubMed ID: 16537830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study.
    Rajan SS; Cai Y; Yi M; Tsai CL; Du XL
    Am J Clin Oncol; 2017 Feb; 40(1):66-74. PubMed ID: 25068470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
    Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
    Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.
    Meyerhardt JA; Li L; Sanoff HK; Carpenter W; Schrag D
    J Clin Oncol; 2012 Feb; 30(6):608-15. PubMed ID: 22253466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
    J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.
    Hamlin PA; Satram-Hoang S; Reyes C; Hoang KQ; Guduru SR; Skettino S
    Oncologist; 2014 Dec; 19(12):1249-57. PubMed ID: 25342313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy.
    Heck JE; Albert SM; Franco R; Gorin SS
    J Am Geriatr Soc; 2008 Sep; 56(9):1687-92. PubMed ID: 18691280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment patterns among elderly patients with stage IV breast cancer treated with HER-2-targeted therapy.
    Lang K; Hao Y; Huang H; Lin I; Rogerio JW; Menzin J
    J Comp Eff Res; 2014 Sep; 3(5):481-90. PubMed ID: 25350800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin or darbepoetin for patients with cancer.
    Tonia T; Mettler A; Robert N; Schwarzer G; Seidenfeld J; Weingart O; Hyde C; Engert A; Bohlius J
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD003407. PubMed ID: 23235597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
    Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma.
    Chen Y; Lairson DR; Chan W; Du XL
    Ann Hematol; 2018 May; 97(5):851-863. PubMed ID: 29333596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of intravenous bisphosphonates in older women with breast cancer.
    Giordano SH; Fang S; Duan Z; Kuo YF; Hortobagyi GN; Goodwin JS
    Oncologist; 2008 May; 13(5):494-502. PubMed ID: 18515734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women With Breast Cancer From 2000 to 2009.
    Du XL; Zhang Y; Hardy D
    Am J Ther; 2016; 23(2):e411-21. PubMed ID: 25756469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries.
    Green AK; Curry M; Trivedi N; Bach PB; Mailankody S
    JAMA Netw Open; 2021 Feb; 4(2):e210030. PubMed ID: 33625507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma.
    Aly A; Johnson C; Yang S; Botteman MF; Rao S; Hussain A
    J Med Econ; 2019 Jul; 22(7):662-670. PubMed ID: 30836812
    [No Abstract]   [Full Text] [Related]  

  • 37. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.
    Du X; Goodwin JS
    J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents.
    Roddy JV; Partridge SM; Rockey ML; Pruemer JM; Guo JJ; Desai SJ; Safa MM
    Am J Clin Oncol; 2010 Feb; 33(1):36-42. PubMed ID: 19652579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer.
    Goyal RK; Carter GC; Nagar SP; Smyth EN; Price GL; Huang YJ; Li L; Davis KL; Kaye JA
    Curr Med Res Opin; 2019 Oct; 35(10):1699-1710. PubMed ID: 31060392
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
    Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
    J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.